|
DBF4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.30520000257906E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55850000005398E-06 |
| Normal-vs-Stage2 |
1.700060E-03 |
| Normal-vs-Stage3 |
2.07150000000045E-05 |
| Normal-vs-Stage4 |
4.986400E-04 |
| Stage1-vs-Stage2 |
5.119400E-01 |
| Stage1-vs-Stage3 |
4.827000E-01 |
| Stage1-vs-Stage4 |
2.696000E-01 |
| Stage2-vs-Stage3 |
9.089200E-01 |
| Stage2-vs-Stage4 |
6.796200E-01 |
| Stage3-vs-Stage4 |
5.557600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23530000006866E-07 |
| Normal-vs-AfricanAmerican |
1.150150E-04 |
| Normal-vs-Asian |
1.479940E-03 |
| Caucasian-vs-AfricanAmerican |
1.169250E-01 |
| Caucasian-vs-Asian |
4.224400E-04 |
| AfricanAmerican-vs-Asian |
9.843700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19750000027175E-07 |
| Normal-vs-Female |
1.61290000022518E-07 |
| Male-vs-Female |
8.617800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.998700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.90519999671213E-08 |
| Normal-vs-Age(61-80Yrs) |
1.59811000000065E-05 |
| Normal-vs-Age(81-100Yrs) |
5.695700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.576400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.904000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.778200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.940000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.437800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.332800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.196500E-03 |
| Normal-vs-Grade 2 |
2.85560000001794E-06 |
| Normal-vs-Grade 3 |
1.76659999995277E-06 |
| Normal-vs-Grade 4 |
5.195400E-04 |
| Grade 1-vs-Grade 2 |
7.353700E-02 |
| Grade 1-vs-Grade 3 |
8.348300E-02 |
| Grade 1-vs-Grade 4 |
3.691600E-01 |
| Grade 2-vs-Grade 3 |
8.376600E-01 |
| Grade 2-vs-Grade 4 |
3.149000E-01 |
| Grade 3-vs-Grade 4 |
3.790600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.362300E-04 |
| Normal-vs-ccB subtype |
2.50719999983495E-07 |
| ccA subtype-vs-ccB subtype |
1.038060E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.74610000084286E-08 |
| Normal-vs-N1 |
9.715600E-03 |
| N0-vs-N1 |
1.391830E-01 |
|
|
